Munteanu M, Tiniakos D, Anstee Q, et al: Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Poynard T, Munteanu M, Charlotte F, et al: Impact of steatosis and inflammation definitions on the performance of NASH tests. Poynard T, Munteanu M, Charlotte F, et al: Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.
Munteanu M, Pais R, Peta V, et al: Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease. Poynard T, Peta V, Munteanu M, et al: The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. BioPredictive: Technical Recommendations for FibroTest, FibroMax, and NASH-FibroTest assays, Bio Predictive. The Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents has set the following guidelines for lipids in children 2 to 17 years of age:įor SI unit Reference Values, see GLUCOSE FASTINGġ. The National Lipid Association and the National Cholesterol Education Program (NCEP) have set the following guidelines for lipids in adults 18 years old and older: A NashTest 2 score of 0.254 will round down to 0.25 and be staged N2.Ġ-6 days: Refer to for information on age-specific (postnatal hour of life) serum bilirubin values.ħ-14 days: or =18 years: or =14 years: 8-48 U/L For example, a NashTest 2 score of 0.245 will round up to 0.25 and be staged N0.
*Boundary values can apply to 2 stages based on rounding.